A detailed history of Catalytic Wealth Ria, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 21,463 shares of MRK stock, worth $2.14 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
21,463
Previous 17,732 21.04%
Holding current value
$2.14 Million
Previous $2.2 Billion 11.03%
% of portfolio
0.43%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$111.15 - $128.97 $414,700 - $481,187
3,731 Added 21.04%
21,463 $2.44 Billion
Q2 2024

Jul 31, 2024

BUY
$123.8 - $132.96 $83,193 - $89,349
672 Added 3.94%
17,732 $2.2 Billion
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $738,551 - $860,577
6,522 Added 61.89%
17,060 $2.25 Billion
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $1.06 Million - $1.15 Million
10,538 New
10,538 $1.15 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Catalytic Wealth Ria, LLC Portfolio

Follow Catalytic Wealth Ria, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalytic Wealth Ria, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalytic Wealth Ria, LLC with notifications on news.